Acceptance or rejection of prophylactic medicine in patients with migraine: A cross-sectional study

British Journal of General Practice

Volumn 58, Issue 547, 2008, Pages 98-101

  Kol, Carianne M C ^a   Dekker, Frans ^a   Knuistingh Neven, Arie ^a   Assendelft, Willem J J ^a   Blom, Jeanet W ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Headache; Migraine; Preventive theraphy; Prophylaxis; Quality of life

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CONSULTATION; CONTROLLED STUDY; DISEASE COURSE; DRUG CHOICE; DRUG PREFERENCE; DRUG USE; FEMALE; FREQUENCY ANALYSIS; GENERAL PRACTICE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATIENT SELECTION; PRESCRIPTION; QUALITATIVE RESEARCH; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOMATOLOGY;

ADULT; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; SEROTONIN AGONISTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 38949217347     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp08X264063     Document Type: Article

References (13)

1. Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002; 58(6): 885-894.
2. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68(5): 343-349.
3. Diamond M, Dahlof C, Papadopoulas G, et al. Topiramate improves health-related quality of life when used to prevent migraine. Headache 2005; 45(8): 1023-1030.
4. Knuistingh NA, Bartelink MEL, De Jongh TOH, et al. Standard for headache of the Dutch College of General Practitioners. Huisarts Wet 2004; 47(9): 411-422.
5. Rahimtoola H, Buurma H, Tijssen CC, et al. Incidence and determinants of migraine prophylactic medication in the Netherlands. Eur J Clin Pharmacol 2002; 58(2): 149-155.
6. Lamberts H, Wood M. International classification of primary care. Oxford: Oxford University Press, 1987.
7. Headache Impact Test (HIT). The Netherlands (Dutch version) 1.1. Qualitymetric, Inc. and GlaxoSmithKline Group of Companies. www.headachetest.com/HIT6/PDFS/Dutch%20Belgium%20.pdf (accessed 10 Jan 2008).
8. Kosinski M, Bayliss MS, Bjorner JB, et al. a six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003; 12(8): 963-974.
9. Bigal ME, Lipton RB. The preventive treatment of migraine. Neurologist 2006; 12(4): 204-213.
10. Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991; 31(5): 333-340.
11. Belam J, Harris G, Kernick D, et al. A qualitative study of migraine involving patient researchers. Br J Gen Pract 2005; 55(11): 87-93.
12. Ridsdale L, Clark LV, Dowson AJ, et al. How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract 2007; 57(538): 388-395.
13. Rasmussen BK. Epidemiology of headache. Cephalalgia 2001; 21(7): 774-777.